Company intelligence / Profile preview

KRISHGEN BioSystems

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~120
Development stage: Other

Overview

KRISHGEN BioSystems manufactures and distributes validated ELISA kits, reagents, and immunoassays for research and diagnostics in areas such as diabetes, oncology, inflammation, and infectious diseases. They commercialized unique assays for insulin analogs, GLP-1 agonists, bispecific antibody drugs, SARS-CoV-2, and have broad global distribution, particularly in the US and Japan[2][3][4][6].

Therapeutic areas: OncologyInfectious DiseasesMetabolic DisordersImmunology
Modalities: Monoclonal antibodyBispecific monoclonal antibodyRecombinant proteinSmall molecule
Industry: Protein Biomarker Diagnostics

Partnerships

Global distributors in the US and Japan for ELISA products[2]Academic linkages for product validation and development[1][5]

Beyond the preview

Go deeper on KRISHGEN BioSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KRISHGEN BioSystems.

Explore the full profile